Purinf
Depression, Anxiety
All Natural Medicine Clinic, LLCPhase 1/2Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 89/ 100
Competitive context
6 Active assets in the Depression, Anxiety cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TENOFOVIR DISOPROXIL FUMARATE Azienda Ospedaliera San Gerardo di Monza | Phase 4 | BB |
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE Massachusetts General Hospital | Phase 4 | BB |
(±)-FTC Azienda Ospedaliera San Gerardo di Monza | Phase 4 | BB |
Azithromycin University of California, San Francisco | Phase 4 | BB |
Hepatitis B Virus Vaccine Eunice Dube | Phase 4 | BB |
View all 19 →
Same molecule, other indications
Purinf is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →